Protocol Ledger

NCT04649489 · Phase III · ACTIVE NOT RECRUITING

A Study to Evaluate Efficacy and Safety of Hepatic Resection for Liver Cancer With PVTT, HVTT or IVCTT After Initial Ate/Bev

Interventional Phase III clinical trial protocol NCT04649489 sponsored by Jia Fan in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2021-04-19 Enrollment: 501 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT04649489
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)501 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04649489
Protocol FieldVerified Registry Value
NCT IdentifierNCT04649489
Consolidated Lead SponsorJia Fan
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment501 participants (ESTIMATED)
Registered Start Date2021-04-19
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI